Valentina Gonzalez-Jaramillo1,2, Valérie Fuhrer3, Nathalia Gonzalez-Jaramillo1,2, Doris Kopp-Heim4, Steffen Eychmüller3, Maud Maessen1,3. 1. Institute of Social and Preventive Medicine (ISPM), University of Bern, Mittelstrasse 43, 3012Bern, Switzerland. 2. Graduate School for Health Sciences, University of Bern, Bern, Switzerland. 3. University Center for Palliative Care, Inselspital University Hospital Bern, University of Bern, Bern, Switzerland. 4. Public Health & Primary Care Library, University Library of Bern, University of Bern, Bern, Switzerland.
Abstract
OBJECTIVE: To assess the effectiveness of home-based palliative care (HBPC) on reducing hospital visits and whether HBPC lowered health care cost. METHOD: We searched six bibliographic databases (Embase (Ovid); Cochrane Central Register of Controlled Trials; Medline (Ovid); PubMed; Web of Science Core Collection; and, CINAHL) until February 2019 and performed a narrative synthesis of our findings. RESULTS: Of the 1,426 identified references, 21 articles based on 19 unique studies met our inclusion criteria, which involved 92,000 participants. In both oncological and non-oncological patients, HBPC consistently reduced the number of hospital visits and their length, as well as hospitalization costs and overall health care costs. Even though home-treated patients consumed more outpatient resources, a higher saving in the hospital costs counterbalanced this. The reduction in overall health care costs was most noticeable for study periods closer to death, with greater reductions in the last 2 months, last month, and last two weeks of life. SIGNIFICANCE OF RESULTS: Stakeholders should recognize HBPC as an intervention that decreases patient care costs at end of life and therefore health care providers should assess the preferences of patients nearing the end-of-life to identify those who will benefit most from HBPC.
OBJECTIVE: To assess the effectiveness of home-based palliative care (HBPC) on reducing hospital visits and whether HBPC lowered health care cost. METHOD: We searched six bibliographic databases (Embase (Ovid); Cochrane Central Register of Controlled Trials; Medline (Ovid); PubMed; Web of Science Core Collection; and, CINAHL) until February 2019 and performed a narrative synthesis of our findings. RESULTS: Of the 1,426 identified references, 21 articles based on 19 unique studies met our inclusion criteria, which involved 92,000 participants. In both oncological and non-oncological patients, HBPC consistently reduced the number of hospital visits and their length, as well as hospitalization costs and overall health care costs. Even though home-treated patients consumed more outpatient resources, a higher saving in the hospital costs counterbalanced this. The reduction in overall health care costs was most noticeable for study periods closer to death, with greater reductions in the last 2 months, last month, and last two weeks of life. SIGNIFICANCE OF RESULTS: Stakeholders should recognize HBPC as an intervention that decreases patient care costs at end of life and therefore health care providers should assess the preferences of patients nearing the end-of-life to identify those who will benefit most from HBPC.
Entities:
Keywords:
Community care; Domiciliary care; Health care cost; Palliative care
Authors: Gabriella Marx; Tina Mallon; Nadine Janis Pohontsch; Franziska Schade; Judith Dams; Manuel Zimansky; Thomas Asendorf; Silke Böttcher; Christiane A Mueller; Michael Freitag; Eva Hummers; Hendrik van den Bussche; Ingmar Schäfer; Hans-Helmut König; Stephanie Stiel; Nils Schneider; Friedemann Nauck; Tim Friede; Martin Scherer Journal: BMJ Open Date: 2022-07-25 Impact factor: 3.006
Authors: Corita R Grudzen; Paige C Barker; Jason J Bischof; Allison M Cuthel; Eric D Isaacs; Lauren T Southerland; Rebecca L Yamarik Journal: Emerg Cancer Care Date: 2022-08-05
Authors: Chloé Schorderet; Caroline H G Bastiaenen; Henk Verloo; Robert A de Bie; Lara Allet Journal: BMC Health Serv Res Date: 2022-09-19 Impact factor: 2.908